Finally, considering the different context-specific and conflicting effects of both heme and Hx on cancer growth and progression, a future definitive classification of Hx as a tumor suppressive/promoting protein could reasonably be excluded, and probably the most promising approach will be to classify and discriminate the precise tumor sub-types that can benefit of each strategy. The gene discussed is HPX; the disease is neoplasm.